echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical World News > "Pharmaceutical leader" market leading policy of basic drugs, red bag Novo Nordisk Q3, China market growth 17%

    "Pharmaceutical leader" market leading policy of basic drugs, red bag Novo Nordisk Q3, China market growth 17%

    • Last Update: 2019-11-06
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    (2019 / 11 / 06) Q3 of Novo Nordisk 2019: China's market grows by 17%; five ministries and commissions support it! Policy review of the pilot cities of the top 10 clinics; Zhengda Tianqing's fourth generation EGFR-TKI enters the clinical practice to overcome the drug resistance problem of oxitinib; Fosun Pharmaceutical's "spin off" action in further gland Pharma plans to be listed in India Great! It's all big cities There have been many changes Don't send me more bargaining links! Drug resistance is an eternal topic There has been a lot of news in India recently Red envelopes! A lot of growth Quite a lot of money.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.